Document is current
Any future updates will be listed below
-
Authors
Membrilla, Javier A. https://orcid.org/0000-0001-6018-6677
Cuadrado, María-Luz
González-García, Nuria
Porta-Etessam, Jesús
Sánchez-Soblechero, Antonio
Lozano Ros, Alberto
Gonzalez-Martinez, Alicia
Gago-Veiga, Ana Beatriz
Quintas, Sonia
Rodríguez Vico, Jaime S.
Jaimes, Alex
Llorente Ayuso, Lucía
Roa, Javier
Estebas, Carlos
Díaz-de-Terán, Javier
- License Information
-
More Information
Article History
Received: 18 April 2024
Accepted: 15 July 2024
First Online: 24 July 2024
Declarations
:
: JAM has received honoraria as a speaker from TEVA and Novartis and for advisory boards from Pfizer. JAM declares no conflict of interest regrading this work. AGM has received speaker honoraria from TEVA. MLC has received honoraria as a speaker for Abbvie-Allergan, Novartis, TEVA, Lundbeck, and for advisory boards from Novartis. ABGV has received honoraria for advisory boards and/or speaker panels from Novartis, Lilly, TEVA, Abbvie-Allergan, Lundbeck and Pfizer. ABGV declares no conflict of interest regarding this work. JDT has received honoraria for advisory boards from Boston Scientific. AGM, NGC, JPE, ASS, ALR, SQ, JRV, AJ, LLA, JR and CE have no conflict of interest to declare. No funding was received for this work.
